학술논문

The role of radiotherapy in patients with refractory Hodgkin's lymphoma after treatment with brentuximab vedotin and/or immune checkpoint inhibitors
Document Type
Article
Source
In Journal of the National Cancer Center March 2024 4(1):86-92
Subject
Language
ISSN
2667-0054